BioSpace News Archive

Xilio Therapeutics, Inc. announced that Marty Huber, M.D., president of research and development and chief medical officer, will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 8:00 a.m. ET.

Pfizer Inc. and ReViral Ltd. announced that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus.

Anavex Life Sciences Corp. announced that Anavex Management Team will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 3:45 PM ET.

Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced the appointment of Wendy L. Dixon, Ph.D., to its Board of directors.

ProMIS Neurosciences, Inc. announced today that it has presented at the American Academy of Neurology (AAN) Annual Meeting held at the Washington State Convention Center in Seattle, April 2-7, 2022.

Tonix Pharmaceuticals Holding Corp. today announced that the first participant was enrolled in the Phase 3 RESILIENT study of TNX-102 SL.

Aptose Biosciences Inc. today announced the appointment of Mr. Philippe Ledru to the position of Chief Commercial Officer.

Labcorp announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock.

HAGAR will present data from two of its completed clinical studies at the upcoming 15th International Conference.

Emergex Vaccines Holding Limited, a company addressing major global infectious disease threats through the development of fully synthetic CD8+ T-Cell Adaptive Vaccines, announces that it has entered into an agreement with ATCC to progress preclinical development of its Yellow Fever booster vaccine program.